Sarah Snider, Ph.D.
Dr. Snider is a postdoctoral associate in the laboratory of Dr. Warren Bickel.
Education and Training
- Virginia Commonwealth University: PhD, Pharmacology & Toxicology
- Allegheny College: BS, Neuroscience & Psychology
Awards and Honors
Member, American Society for Pharmacology and Experimental Therapeutics
Member, Association for Behavioral Analysis International
Second Place Poster Award, VAS, 2013
Anthony Ambrose Awardee, Virginia Commonwealth University, 2013 Inaugural travel awardee, Society for the Experimental Analysis of Behavior, 2012
- Bickel WK, Moody L, Snider SE, Mellis AM, Stein JS, Quisenberry AJ. (2016). The behavioral economics of tobacco products: Innovations in laboratory methods to inform regulatory science. In: Hanoch Y, Rice T, Barnes A (Ed.), Behavioral Economics and Health Behaviors: Key Concepts and Current Research.
- Snider SE, Vunck SA, Van den Oord EJ, Adkins DE, McClay JL, Beardsley PM. (2013). The glial cell modulators, ibudilast and its amino analog, AV1013, attenuate methaphetamine locomotor activity and its sensitization in mice. European Journal of Pharmacology 679(1): 75-80.
- Snider SE, Hendrick ES, Beardsley PM. (2013). Glial cell modulators attenuate methamphetamine self-administration in the rat. European Journal of Pharmacology 701(1): 124-130.